HomeKALV • NASDAQ
add
Kalvista Pharmaceuticals Inc
Previous close
$8.77
Day range
$8.71 - $9.09
Year range
$7.30 - $16.88
Market cap
433.40M USD
Avg Volume
346.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.20M | 174.01% |
Net income | -42.27M | -52.87% |
Net profit margin | — | — |
Earnings per share | -0.91 | -13.75% |
EBITDA | -45.58M | -54.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 135.78M | 31.60% |
Total assets | 160.83M | 15.92% |
Total liabilities | 26.84M | 10.46% |
Total equity | 133.99M | — |
Shares outstanding | 49.42M | — |
Price to book | 2.83 | — |
Return on assets | -63.44% | — |
Return on capital | -71.75% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -42.27M | -52.87% |
Cash from operations | -39.64M | -99.96% |
Cash from investing | 48.67M | 70.45% |
Cash from financing | 295.00K | 130.47% |
Net change in cash | 9.73M | 17.88% |
Free cash flow | -28.26M | -103.94% |
About
Founded
2004
Website
Employees
150
